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ABSTRACT: The wide usage and subsequent leakage of
nonsteroidal anti-inﬂammatory drugs (NSAIDs) into the
environment present an urgent need to create materials for
selective binding of NSAID drugs, which are highly similar to
one another in structure and functionality. Surface−core
double-cross-linking of cationic micelles containing Naproxen
or Indomethacin as the template yielded molecularly
imprinted nanoparticles (MINPs) for these drugs. The
nanoparticle receptors resembled water-soluble proteins in
their hydrophilic exterior and hydrophobic core with guest-
tailored binding pockets. Their binding selectivity for their
templates over other NSAID analogues rivaled that of antibodies prepared through much lengthier procedures.
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■ INTRODUCTION
The immune system has remarkable abilities to generate
antibodies for virtually any molecule of biological interest. The
strong and speciﬁc recognition of antigens by their antibodies is
at the heart of immune response and vital to the biological
host’s survival. Their extraordinary molecular recognition also
makes antibodies powerful tools in diagnostics, therapeutics,
imaging, analysis, and elucidation of biological mechanisms.1
However, antibodies are expensive biomolecules requiring
lengthy procedures to produce. Immunization of animals itself
often takes weeks of time, even if the molecules readily elicit
immune responses. The (polyclonal) antibodies generated then
need to be isolated and puriﬁed. Monoclonal antibodies are
even more cumbersome to prepare, as they need to come from
a single cell line. Just like any proteins, antibodies are subject to
denaturation, whether by adverse temperatures, adsorption to
surfaces, or exposure to organic solvents, surfactants, or other
chemical entities.
Chemists for decades have tried to create receptors for
molecules of interest,2,3 in a way similar to what nature does
with antibodies. Although remarkable receptors have been
made, sometimes with biological kind of aﬃnity and
speciﬁcity,4−6 synthetic receptors tend to be limited to speciﬁc
classes of molecules or ions and a general method to create
strong and speciﬁc antibody-resembling receptors remains an
elusive goal.
Nonsteroidal anti-inﬂammatory drugs (NSAIDs) are one of
the most used over-the-counter drugs (see Chart 1 for selected
structures).7 Because of their wide usage and subsequent
leakage into the environment, there is high interest in
monitoring and detecting them in natural settings.8 In addition
to chemical methods, enzyme-linked immunosorbent assays
(ELISA), which rely on NSAID-speciﬁc antibodies for
operation, have been used for NSAID drug analysis.9,10 The
challenge in designing antibody-like receptors for these drugs
(1−5) lies in their structural similarity: all have a carboxylate
and a hydrophobic aromatic moiety. Naproxen and Ibuprofen
(or Ketoprofen) in particular resemble one another, even in the
size and shape of the aromatic group. Needless to say, to
recognize these drugs selectively, the receptor needs to have
remarkable precision in its binding. Ideally, one also needs the
receptors to function in water for drug monitoring or analysis.
Herein, we report that antibody-like polymeric nanoparticle
receptors can be created for NSAIDs through molecular
Received: January 26, 2015
Accepted: May 14, 2015
Published: May 14, 2015
Chart 1. Structures of Common NSAIDs
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imprinting in cross-linked micelles. The binding selectivity
displayed by our “synthetic antibodies” was comparable to that
found in biologically generated antibodies. Our materials,
however, can be produced in 2−3 days rather than weeks
without special techniques, provided that the building blocks
(the polymerizable surfactants and cross-linkers) are available.
■ RESULTS AND DISCUSSION
The synthesis of our nanoparticle receptors starts with
micellization of cationic surfactant 6 above its critical micelle
concentration (CMC) of 0.55 mM in water (Scheme 1).
Because the headgroup of this surfactant is a tripropargylam-
monium cation, its micellization places a layer of terminal
alkynes on the surface of the micelle. In the presence of a
diazide cross-linker (7) and Cu(I) catalysts, the highly eﬃcient
copper-catalyzed alkyne−azide cycloaddition11 quickly cross-
links the surface of the micelles to aﬀord alkynyl-SCMs as
water-soluble nanoparticles.
In our previous work, we have shown that water- or organic-
soluble azide-functionalized ligands could be easily installed on
the SCM surface if a suﬃcient number of alkyne groups are left
on the surface of the cross-linked micelles.12−15 This feature
was achieved by using a ratio of [6]/[7] = 1:1.2 during the
SCM preparation, as an excess of alkynes will be left after cross-
linking. The alkynyl-SCMs were functionalized with sugar-
derived ligand 8 so that the resulting nanoparticles were highly
hydrophilic on the surface and completely soluble in water.
The details of the molecular imprinting procedure has been
reported previously.16 Brieﬂy, the anionic and hydrophobic
nature of the NSAID (e.g., 1 or 2) allowed it to be readily
incorporated into the cationic micelle and the resulting SCM.
After the surface cross-linking and functionalization, we
initiated core cross-linking of the methacrylate of 6 around
the template. This step is the key to the molecular imprinting to
form the ﬁnal binding pocket. To facilitate this process, we
solubilized 1 equiv. of divinylbenzene (DVB) and 5 mol % of
2,2-dimethoxy-2-phenylacetophenone (DMPA, a photolytic
radical initiator) in the very beginning of the preparation and
irradiated the surface-functionalized SCMs with UV light. UV
irradiation initiated free radical polymerization between the
methacrylate and DVB. Because the template molecule (1 or 2)
had neither alkyne nor methacrylate to participate in any cross-
linking, it acted as a place holder throughout the preparation
while surface- and core cross-linking took place around the
template to aﬀord the binding pocket.
Molecularly imprinted polymers (MIPs)17−25 have been
reported in the literature for NSAID drugs.26−29 They are
typically prepared by polymerization of a functionalized
monomer such as 4-vinylpyridine that binds the carboxylic
acid of the NSAID and a large amount of a vinyl cross-linker.
The bulk polymerization normally yields insoluble cross-linked
polymers that need to be ground into smaller particles, sieved,
and washed. In contrast, because the core-cross-linking was
conﬁned with each SCM in our case, the ﬁnal molecularly
imprinted nanoparticles (MINPs) were water-soluble nano-
particles similar to water-soluble proteins in size, hydrophilic
exterior, hydrophobic interior, and a speciﬁc binding pocket in
the hydrophobic core.
The MINP synthesis was monitored by 1H NMR spectros-
copy and dynamic light scattering (DLS). The SCMs had been
characterized earlier additionally by mass spectrometry (after
cleaving the 1,2-diol cross-linkages) and TEM.12 Upon surface-
cross-linking, all the 1H NMR signals of surfactant 6 showed
characteristic broadening (Figure S1). The alkenic and aromatic
protons of both 6 and DVB remained clearly visible in the
SCMs but disappeared after the core-cross-linking. The
disappearance of the alkenic protons should be caused by
their consumption by the polymerization. The aromatic
protons disappeared most likely because the high cross-linking
density of the core restrained their movements in the core. DLS
showed that the alkynyl-SCM, the surface-functionalized SCM,
and the ﬁnal MINP-1 (i.e., MINP prepared with 1 as the
template) had an average size of 4.0, 6.3, and 5.0 nm,
respectively (Figure S2). The size change was consistent with
our previous results,16 suggesting that the nanoparticles became
larger upon surface decoration and shrank during core-cross-
linking.
The MINPs were puriﬁed by precipitation from acetone and
repeated washing with water/acetone and methanol/acetic acid.
The yield of the ﬁnal MINPs was typically >80%. The
ﬂuorescence of Naproxen allowed us to monitor its removal
from MINP-1 by the disappearance of its characteristic
emission peak at 360 nm. The carboxylate of the template
served two strategic purposes in our imprinting: ﬁrst, its anionic
charge enabled it to interact with the cationic micelle and,
ultimately, the MINP, by electrostatic interactions in addition
to hydrophobic eﬀect; second, its hydrophilic nature ensured its
location on the micelle surface and thus prevented permanent
trapping of the template inside the MINP during polymer-
ization. According to DLS, the ﬁnal MINP-1 averaged 5.0 nm
in diameter, which translated to a molecular weight of 51 000
Da (Figure S3). In the calculation of the molecular weight, the
DLS program assumed the power law for the dependency of
the MW on the size of the particle. Typical parameters for
proteins were used for the MINPs since both proteins and
MINPs were compact in the interior (see the Supporting
Information for details).30 Following the same procedures, we
Scheme 1. Preparation of MINP with Naproxen as the
Template
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also prepared MINP-2 against Indomethacin and characterized
the materials similarly (Figures S4−S6).
In traditional MIPs, the insolubility of the receptors means
that binding needs to be determined indirectly, often by
measuring the amounts of guest absorbed by diﬀerent amounts
of polymer beads.17−25 Neither the number of binding sites on
a polymer bead nor their binding aﬃnity can be controlled, as
the polymer beads are obtained by grinding and sieving of
insoluble macroporous polymers. A heterogeneous population
of binding sites is typically obtained from such imprinting.
The water-solubility of MINP-1 and the ﬂuorescence of
Naproxen enabled us to directly study the binding of MINP-1
as a receptor by ﬂuorescence titration. Direct characterization
by spectroscopic methods is a highly desired feature for
molecular imprinted materials and is often diﬃcult in
traditional insoluble MIPs.31 Good solubility and spectroscopic
characterization could make our MINPs useful sensors for the
drugs to be studied. As shown by Figure 1, upon titration of
Naproxen by diﬀerent concentrations of MINP-1 in an aqueous
Tris buﬀer (50 mM Tris, pH 7.4),32 the emission peak of the
guest at 358 nm gradually decreased and a new peak at 430 nm
emerged. The data ﬁt nearly perfectly to a 1:1 binding isotherm
to aﬀord a binding constant (Ka) of (1.1 ± 0.2) × 10
6 M−1. The
binding constant translates to a binding free energy of −ΔG =
8.2 kcal/mol.
As mentioned earlier, a successful receptor for NSAIDs not
only needs to have strong binding but also low cross-reactivity
with its structural analogues. Because Naproxen is the only
ﬂuorescent molecule among the NSAIDs chosen, we turned to
isothermal titration calorimetry (ITC) to study the binding of
the other drugs by MINP-1. As shown by Figure 2a, the
titration data for Naproxen and MINP-1 yielded a Ka value of
(0.91 ± 0.04) × 106 M−1, experimentally the same as the value
obtained from the ﬂuorescence titration.
Having conﬁrmed the good agreement between the
ﬂuorescence and ITC binding data, we proceeded with the
ITC binding studies of the other NSAIDs (2−5) by MINP-1.
Recognizing the structural and functional-group similarity
between the template (Naproxen) and Ibuprofen or
Ketoprofen, we were apprehensive whether the MINP was
able to distinguish these structural analogues.
The Ka values for 2, 3, 4, and 5 were determined to be 8.0 ×
103, 8.7 × 104, 2.9 × 104, and 3.7 × 104 M−1, respectively
(Table 1, entries 3−6). Thus, the binding constants for these
other NSAIDs by MINP-1 were at least an order of magnitude
weaker than that for the Naproxen template. In the literature,
the speciﬁcity of an antibody is represented by its cross-
reactivity with ligands analogous to its antigen; the cross-
reactivity may be obtained from either ITC binding data33 or
antibody-based assays such as ELISA.9 The binding constants in
our studies translate to cross-reactivity of 0.01, 0.1, 0.03, and
0.04 for 2 (Indomethacin), 3 (Ibuprofen), 4 (Ketoprofen), and
5 (Diclofenac), respectively.
In the literature, polyclonal antibodies have been prepared
for Naproxen.9 The immunization (of rabbits) was reported to
take 25 weeks. Competitive ELISA was then used to determine
the speciﬁcity of the antibody for both NSAID and other
analogues. The cross-reativity for Ibuprofen and Diclofenac was
0.09 and 0.04, respectively.9 Thus, the speciﬁcity displayed by
our plastic antibodies were essentially identical to that exhibited
by the antibodies generated through much lengthier and more
expensive procedures.
Because all the NSAIDs studied carry the identical
carboxylate, the selectivity of our MINP should derive from
the size/shape of the binding pocket. In other words,
hydrophobic matching between the host and the guest was
responsibile for the selectivity. We were delighted to see that
Ibuprofen and Ketoprofen, two extremely similar analogues of
Naproxen could be distinguished nicely by MINP-1.
Figure 1. (a) Fluorescence emission spectra of 1 (λex = 310 nm) upon
addition of diﬀerent concentrations of MINP-1. (b) Nonlinear least-
squares curve ﬁtting of the emission intensity of 1 at λ = 358 nm as a
function of MINP-1 concentration. [1] = 0.25 μM.
Figure 2. ITC titration curves obtained at 298 K for the binding of (a)
1 by MINP-1 and (b) (a) 2 by MINP-2. The data correspond to
entries 1 and 7 in Table 1. Additional ITC titration curves can be
found in the Figures S7 and S8.
Table 1. Binding Data for MINPs Obtained by ITCa
entry guest host
Ka
(× 104 M−1)
-ΔG
(kcal/mol) CRRb N
1 1 MINP-1 112 ± 20 8.2 c c
2 1 MINP-1 91 ± 4 8.1 1 0.6 ± 0.1
3 2 MINP-1 0.8 ± 0.1 5.6 0.01 1.1 ± 0.1
4 3 MINP-1 8.7 ± 0.5 6.7 0.1 1.0 ± 0.1
5 4 MINP-1 2.9 ± 0.4 6.1 0.03 0.9 ± 0.1
6 5 MINP-1 3.7 ± 0.2 6.2 0.04 1.1 ± 0.1
7 2 MINP-2 98 ± 5 8.2 1 1.1 ± 0.1
8 1 MINP-2 5.2 ± 1.2 −6.4 0.05 0.7 ± 0.1
9 3 MINP-2 8.0 ± 0.1 −6.7 0.08 0.6 ± 0.1
10 4 MINP-2 0.8 ± 0.1 −5.3 0.01 0.4 ± 0.1
11 5 MINP-2 9.4 ± 1.0 −6.8 0.10 0.4 ± 0.1
aThe titrations were generally performed in duplicates in 50 mM Tris
buﬀer (pH 7.4) and the errors between the runs were <15%. bCRR =
cross-reactivity = binding constant of a given compound by a MINP
receptor normalized to that of the template by the same MINP. cThe
binding constant was obtained from ﬂuorescence titration and thus
was not compared with the ITC binding data.
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Apparently, the binding pocket was so well formed that even an
insertion of a single ketone in the middle of the aromatic
moiety (in Ketoprofen) was not tolerated by the binding
pocket.
Another feature of our MINP is its controllable number of
binding sites. The ITC titration revealed that the number of
binding site per particle averaged 0.6−1.1. The number agreed
well with our prepration: since the micelle aggreation number
was ca. 50 and the [template]/[surfactant] ratio was 1:50 in our
MINP prepration,9 we anticipated a single binding site per
particle on average. The number of binding sites obtained also
compared favorably with typical numbers of protein/antibody
receptors, as inactive receptors, impurities, and inaccuracies in
the molecular weight of the materials frequently cause diviation
of the binding site from unity, even when the orignial
bioreceptor contains a single binding site.33 It should be
mentioned that the average number of binding sites per particle
could be easily tuned by the [template]/[surfactant] ratio, as
demonstrated by our previous work.16a
Indomethacin (2) was the largest NSAID drug in our study.
Because it is generally easier to ﬁt a smaller molecule in a larger
binding pocket than vice versa, we were especially curious
about the speciﬁcity of MINP-2 for these NSAIDs. As shown in
Table 1 (entry 7, see Figure 2b for the titration curve), the
binding constant of MINP-2 for the template itself was (0.98 ±
0.05) × 106 M−1, very similar to the value for Naproxen by
MINP-1. Because Indomethacin is signﬁcantly larger in size
than Naproxen, one would anticipate that the binding of the
larger ligand by its correspoinding MINP receptor should be
stronger, as a major driving force in the binding should be the
expulsion of the water molecules in the binding pocket by the
corresponding ligand and a larger guest should expel more
water molecules from the (larger) binding pocket.
There could be several possible reasons why the larger
Indomethacin did not display stronger binding than the smaller
Naproxen. First, Indomethacin contained an amide group in
the structure. The amide carbonyl oxygen is an excellent
hydrogen-bond acceptor and is expected to be solvated quite
well by water prior to its entrance into the binding pocket.
Desolvation of the guest costs free energy and is expected to
negatively impact the binding aﬃnity. Second, if the amide
group was hydrophilic enough to stay near the surface of the
micelle during molecular imprinting, the binding pocket
obtained from Indomethacin in MINP-2 could be shallower
than that obtained from Naproxen in MINP-1. If this is indeed
the case, the shallower binding pocket would reduce the
hydrophobic driving force for the binding, as part of the guest
molecule might still be exposed to water after the binding. In
contrast, a more deeply embedded binding pocket should bury
the hydrophobic guest more completely; thus, the smaller but
overall more hydrophobic aromatic group in Naproxen might
be better shielded from water by its binding pocket. Third, a
rigid aromatic group (of Naproxen and the top protion of
Indomethacin) has little conformational freedom, whereas the
tertiary amide bond of Indomethacin could adopt either trans
or cis conﬁguration prior to binding. Because binding will ﬁx
the conformation of the guest (by ﬁtting the guest into the
preformed binding pocket), the loss of conformaitonal entropy
will also lower the potential driving force for the binding.
Although the binding for Indomethacin was not signﬁicantly
stronger than for Naproxen by their corresponding MINPs, it is
encouraging to see that MINP-2 remained highly selective. The
cross-reactivity of this MINP was 0.05, 0.08, 0.01, and 0.1 for 1
(Naproxen), 3 (Ibuprofen), 4 (Ketoprofen), and 5 (Diclofe-
nac), respectively. Thus, similar to MINP-1, the highest cross-
reactivity for the nontemplated NSAIDs was 0.1, similar to
what was observed for the natural antibodies.
A close examination of our binding data suggests that a
smaller guest indeed can ﬁt into a larger pocket more easily
than a larger guest does a smaller pocket. For example, the
cross-reactivity of Indomethacin relative to Naproxen in MINP-
1 was 0.01, indicating that the large guest had diﬃculty ﬁtting
into the binding pocket generated by the small guest. The
cross-reactivity of Naproxen to Indomethacin in MINP-2,
however, was 0.05. Thus, although the pocket was quite
selective for the NSAIDs studied, relatively speaking, a small
guest indeed ﬁtted better to a larger pocket than vice versa.
■ CONCLUSIONS
Traditionally, chemists use molecular synthesis to create
discrete, well-deﬁned molecular receptors for molecules of
interest.2,3 However, building concave receptors with guest-
complementary binding surfaces require ingenious molecular
design, lengthy synthesis, and many times is simply impossible
for complex shaped/functionalized molecules or simple
molecules lacking proper functional-group handles. As shown
in this study, the great similarity and subtle diﬀerences among
the NSAIDs make it extremely challenging to create speciﬁc
molecular receptors for them. Although one could turn to
biological methods to generate antibodies for the drugs, the
procedures involve lengthy immunization and cumbersome
puriﬁcation and the resulting biomolecules are unstable under
many conditions. In contrast, our molecular imprinting in
cross-linked micelles readily yielded “synthetic antibodies” with
antibody-like speciﬁcity. Although higher binding aﬃnities
(than the current micromolar aﬃnities) would be even better,
the ease of the synthesis, the diversity of the MINP receptors
that can be created, the strong tolerance of the materials for
organic solvent and high temperatures because of their high
cross-linking density,16 and the excellent molecular recognition
of the materials suggest that MINPs could become attractive
substitutes for antibodies in appropriate applications.
■ EXPERIMENTAL SECTION
General. Methanol, methylene chloride, and ethyl acetate were of
HPLC grade and were purchased from Fisher Scientiﬁc. All other
reagents and solvents were of ACS-certiﬁed grade or higher, and were
used as received from commercial suppliers. Routine 1H and 13C NMR
spectra were recorded on a Bruker DRX-400 or on a Varian VXR-400
spectrometer. ESI-MS mass was recorded on Shimadzu LCMS-2010
mass spectrometer. Fluorescence spectra were recorded at ambient
temperature on a Varian Cary Eclipse Fluorescence spectrophotom-
eter. ITC was performed using a MicroCal VP-ITC Microcalorimeter
with Origin 7 software and VPViewer2000 (GE Healthcare, North-
ampton, MA). Dynamic light scattering (DLS) was performed on a
PD2000DLS+ dynamic light scattering detector.
Typical MINP Synthesis. To a micellar solution of surfactant 6
(9.3 mg, 0.02 mmol) in D2O (2.0 mL), divinylbenzene (DVB, 2.8 μL,
0.02 mmol), 1 in D2O (10 μL of a solution of 10.1 mg/mL, 0.0004
mmol), and 2,2-dimethoxy-2-phenylacetophenone (DMPA) in DMSO
(10 μL of a 12.8 mg/mL, 0.0005 mmol) were added.34 The mixture
was ultrasonicated for 10 min. Compound 6 (4.1 mg, 0.024 mmol),
CuCl2 in D2O (10 μL of 6.7 mg/mL, 0.0005 mmol), and sodium
ascorbate in D2O (10 μL of 99 mg/mL, 0.005 mmol) were then added
and the reaction mixture was stirred slowly at room temperature for 12
h. Compound 8 (10.6 mg, 0.04 mmol), CuCl2 (10 μL of a 6.7 mg/mL
solution in D2O, 0.0005 mmol), and sodium ascorbate (10 μL of a 99
mg/mL solution in D2O, 0.005 mmol) were then added and the
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solution stirred for another 6 h at room temperature. The reaction
mixture was transferred to a glass vial, purged with nitrogen for 15
min, sealed with a rubber stopper, and irradiated in a Rayonet reactor
for 12 h. 1H NMR spectroscopy was used to monitor the progress of
reaction. The reaction mixture was poured into acetone (8 mL). The
precipitate was collected by centrifugation and washed with a mixture
of acetone/water (5 mL/1 mL) three times. The crude product was
washed with methanol/acetic acid (5 mL/0.1 mL) ﬁve times, and then
with methanol (2 mL), followed by excess acetone. The oﬀ-white
product was dried in air to aﬀord the ﬁnal MINPs (17 mg, 85%).
Determination of Binding Constants. For ﬂuorescence titration,
a stock solution of MINP-1 (4.0 × 10−4 M) in Tris buﬀer (50 mM
Tris, pH 7.4) was added to a solution of Naproxen in the same buﬀer
(0.25 μM). The excitation wavelength was 310 nm. The association
constant (Ka) was obtained by nonlinear least-squares curve ﬁtting of
the emission intensity of Naproxen at 358 nm following standard
procedures.35 The determination of binding constants by ITC also
followed standard procedures.36−38 Speciﬁcally, an aqueous solution of
compound 1 (1.20 mM) in Tris buﬀer (50 mM Tris, pH 7.4) was
injected in equal steps of 10 μL into 1.43 mL of a solution of MINP-1
(0.10 mM) in the same buﬀer at intervals of 120 s for a total of 30
injections. The heat of dilution for compound 1, obtained by injecting
an aqueous solution of compound 1 (1.20 mM) in Tris buﬀer (50 mM
Tris, pH 7.4) into the buﬀer, was subtracted from the heat released
during the binding. Curve ﬁtting was achieved using Microcal’s Origin
7 software (MicroCal VP-ITC, Northampton, MA) that autogenerates
the binding parameters.
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